Skip to main content
Fig. 1 | BMC Gastroenterology

Fig. 1

From: Effects of endoscopic injection sclerotherapy for esophagogastric varices on portal hemodynamics and liver function

Fig. 1

Flowchart for patient selection. Between November 2001 and November 2016, 224 patients with EGV were treated with EIS. We excluded 123 patients with hepatocellular carcinoma. Eventually, 58 patients who provided written informed consent, were enrolled in this study. We divided patients into two groups, namely increased group (IG) and decreased group (DG) following endoscopic sclerotherapy

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us